Inventor · disambiguated record
Karsten Henco
Also filed as: HENCO KARSTEN
26 granted patents·16 pending applications·1,190 citations·filing 1986–2023
97Inventor score
Top patents by PatentIndex Score
42 records- 0192US5652141ADevice and process for isolating nucleic acids from cell suspensionOIAGEN GMBH·Filed 1995·Granted Jul 29, 1997·202 cites·12 claims
- 0291US6020186ADevice and process for isolating nucleic acids from cell suspensionsQIAGEN GMBH·Filed 1995·Granted Feb 1, 2000·126 cites·3 claims
- 0390US5871908AProcess for the determination of in vitro amplified nucleic acidsEVOTEC BIOSYSTEMS GMBH·Filed 1993·Granted Feb 16, 1999·239 cites·43 claims
- 0489US10874725B2Method of providing patient specific immune response in amyloidoses and protein aggregation disordersUNIV NEW YORK·Filed 2017·Granted Dec 29, 2020·4 cites·19 claims
- 0589US5057426AMethod for separating long-chain nucleic acidsDIAGEN INST FUR MOLEKULAR BIOL·Filed 1987·Granted Oct 15, 1991·233 cites·21 claims
- 0685US6582903B1Method and a device for the evaluation of biopolymer fitnessEVOTEC AG·Filed 1998·Granted Jun 24, 2003·104 cites·115 claims
- 0781US9370531B2Method of providing patient specific immune response in amyloidoses and protein aggregation disordersHENCO KARSTEN·Filed 2008·Granted Jun 21, 2016·6 cites·11 claims
- 0881US5795747AProcess for manufacturing new biopolymersEVOTEC BIOSYSTEMS GMBH·Filed 1995·Granted Aug 18, 1998·85 cites·12 claims
- 0979US11179417B2Method for obtaining globally activated monocytesTRANSIMMUNE AG·Filed 2015·Granted Nov 23, 2021·2 cites·5 claims
- 1076US7241569B2Method and a device for the evaluation of biopolymer fitnessOLYMPUS CORP·Filed 2003·Granted Jul 10, 2007·13 cites·42 claims
- 1173US7534576B2Method and a device for the evaluation of biopolymer fitnessOLYMPUS CORP·Filed 2007·Granted May 19, 2009·6 cites·2 claims
- 1268US11975120B2Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing materialMEDODERM GMBH·Filed 2022·Granted May 7, 2024·0 cites·17 claims
- 1367US12364755B2Method for obtaining globally activated monocytesTRANSIMMUNE AG·Filed 2021·Granted Jul 22, 2025·0 cites·13 claims
- 1466US2021361754A1Method of providing patient specific immune response in amyloidoses and protein aggregation disordersUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 1566US2024093151A1Device and method for obtaining immuno-stimulatory antigen-presenting cellsTRANSIMMUNE AG·Filed 2023·Application pending·0 cites
- 1665US11311644B2Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing materialMONTENEGRO RIVELINO·Filed 2019·Granted Apr 26, 2022·0 cites·17 claims
- 1765US7202953B1Scanning microscopic method having high axial resolutionEVOTEC BIOSYSTEMS AG·Filed 1999·Granted Apr 10, 2007·35 cites·34 claims
- 1865US5795720AProcess and device for the separation and detection of components of a mixture of materials by temperature gradient gel electrophoresisQIAGEN GMBH·Filed 1995·Granted Aug 18, 1998·37 cites·12 claims
- 1965US2009194706A1Method and device for the selective withdrawal of compontents from complex mixturesEVOTEC BIOSYSTEMS GMBH·Filed 2009·Application pending·0 cites
- 2060US2022259556A1Method for obtaining immuno-suppressive dendritic cellsTRANSIMMUNE AG·Filed 2021·Application pending·0 cites
- 2160US2022112462A1Method for obtaining immuno-stimulatory dendritic cellsTRANSIMMUNE AG·Filed 2021·Application pending·0 cites
- 2257US5637455AHIV-2 virus variantsQIAGEN GMBH·Filed 1994·Granted Jun 10, 1997·14 cites·14 claims
- 2356US6849461B2Method and device for the selective withdrawal of components from complex mixturesEVOTEC AG·Filed 1995·Granted Feb 1, 2005·26 cites·21 claims
- 2455US2025375477A1Selective tolerization - methods of selectively generating tolerogenic dendritic cellsTRANSIMMUNE AG·Filed 2022·Application pending·0 cites
- 2554US2005250157A1Method and device for the selective withdrawal of components from complex mixturesEVOTEC BIOSYSTEMS GMBH·Filed 2004·Application pending·0 cites
- 2653US2016354451A1Method of providing patient specific immune response in amyloidoses and protein aggregation disordersUNIV NEW YORK·Filed 2016·Application pending·0 cites
- 2752US2023381217A1Liquid composition for use in the prevention or reduction of skin irritation, allergy and/or an infectious diseaseMEDODERM GMBH·Filed 2021·Application pending·0 cites
- 2851US7015017B2Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomenaEVOTEC BIOSYSTEMS AG·Filed 2001·Granted Mar 21, 2006·0 cites·10 claims
- 2951US2022211606A1Liquid composition for influencing the microbiota on a subject's skin comprising chitosanMEDODERM GMBH·Filed 2020·Application pending·0 cites
- 3050US4912044APreparation of mesophilic microorganisms which contain a D-hydantoinase which is active at elevated temperatureBASF AG·Filed 1986·Granted Mar 27, 1990·14 cites·5 claims
- 3150US2016298082A1Method for obtaining immuno-stimulatory dendritic cellsTRANSIMMUNE AG·Filed 2014·Application pending·0 cites
- 3249US2010021939A1Process for detecting enzyme activity in an immunoassayKRAEMER JOACHIM·Filed 2009·Application pending·0 cites
- 3348US9439998B2Compositions and methods for disinfecting materialsHENCO KARSTEN·Filed 2010·Granted Sep 13, 2016·0 cites·44 claims
- 3445US6213735B1Micromechanical ejection pump for separating small fluid volumes from a flowing sample fluidEVOTEC BIOSYSTEM AG·Filed 1997·Granted Apr 10, 2001·31 cites·16 claims
- 3545US2016130552A1Method for obtaining immuno-suppressive dendritic cellsTRANSIMMUNE AG·Filed 2014·Application pending·0 cites
- 3643US2003235873A1Process for detecting enzyme activity in an immunoassayFiled 2001·Application pending·0 cites
- 3741US5677147AHIV-2 virus variantsQIAGEN GMBH·Filed 1996·Granted Oct 14, 1997·3 cites·4 claims
- 3840US5849545ASubstrate material for simultaneously binding genotypic and phenotypic substancesEVOTEC BIOSYSTEMS GMBH·Filed 1997·Granted Dec 15, 1998·5 cites·15 claims
- 3939US2018195042A1Device and method for obtaining immuno-stimulatory antigen-presenting cellsTRANSIMMUNE AG·Filed 2016·Application pending·0 cites
- 4033US2013157887A1Discrete states for use as biomarkersBELEUT MANFRED·Filed 2011·Application pending·0 cites
- 4127US6423516B1Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomenaEVOTEC BIOSYSTEMS AG·Filed 1993·Granted Jul 23, 2002·2 cites·14 claims
- 4224US6156529AMethod for specifically marking a proteinEVOTEC BIOSYSTEMS AG·Filed 1998·Granted Dec 5, 2000·3 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →